Placebo-Controlled Trial of Cytisine for Smoking Cessation
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cytisine, a partial agonist that binds with high affinity to the α(4)β(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS: We conducted a single-center, randomized, double-blind, placebo-controlled trial. Participants were randomly assigned to receive cytisine or matching placebo for 25 days; participants in both groups received a minimal amount of counseling during the study. The primary outcome measure was sustained, biochemically verified smoking abstinence for 12 months after the end of treatment. Of 1542 adult smokers screened, 740 were enrolled and 370 were randomly assigned to each study group. RESULTS: The rate of sustained 12-month abstinence was 8.4% (31 participants) in the cytisine group as compared with 2.4% (9 participants) in the placebo group (difference, 6.0 percentage points; 95% confidence interval [CI], 2.7 to 9.2; P=0.001). The 7-day point prevalence for abstinence at the 12-month follow-up was 13.2% in the cytisine group versus 7.3% in the placebo group (P=0.01). Gastrointestinal adverse events were reported more frequently in the cytisine group (difference, 5.7 percentage points; 95% CI, 1.2 to 10.2). CONCLUSIONS: In this single-center study, cytisine was more effective than placebo for smoking cessation. The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“Purportedly, every year that a smoker delays quitting beyond the mid-30s subtracts 3 months of life expectancy.(2) However, of the more than 1 billion smokers around the globe, two thirds reside in countries where the average household income is less than $200 per week and where therapy for this kind is not paid for b…”
BackgroundMoher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Assessment of Depression: The Depression Inventory
Beck, A. T., & Beamesderfer, A. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395074 · Cited by 1,832
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,431
Shape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414 · cited 1×
“It is a highly addictive habit, with more than 95% of unaided attempts at cessation failing to last 6 months.(1) Purportedly, every year that a smoker delays quitting beyond the mid-30s subtracts 3 months of life expectancy.”
BackgroundAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Self-citation
Research works printed but not linked: 5
- Cahill K, 2010, Cochrane Database Syst Rev, 12, CD006103
- Stead LF, 2008, Cochrane Database Syst Rev, 1, CD000146
- Hughes JR, 2007, Cochrane Database Syst Rev, 1, CD000031
- Tutka P, 2006, Pharmacol Rep, 58, 777
- Stoyanov S, 1965, Chimpharm Sofia, 2, 13
Cited by
Items 101–200 of 234
Laikowski, M. M., Reisdorfer, F., & Moura, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410105135 · Cited by 18
Agonist and antagonist effects of cytisine in vivo
Radchenko, E. V., Драволина, О. А., & Bespalov, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.019 · Cited by 20
Cytisine — A Tobacco Treatment Hiding in Plain Sight
Rigotti, N. A. (2014) · New England Journal of Medicine · doi:10.1056/nejme1412313 · Cited by 17
Tutka, P., Kondrat-Wrobel, M. W., Załuska-Ogryzek, K., Żółkowska, D., Florek-Łuszczki, M., & Łuszczki, J. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4461-0 · Cited by 16
Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice
Tutka, P., Mróz, T., Bednarski, J., Styk, A., Ognik, J., Mosiewicz, J., & Łuszczki, J. J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)70978-2 · Cited by 18
Reducing Lung Cancer and Other Tobacco-Related Cancers in Europe: Smoking Cessation Is the Key
Clancy, L. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0085 · Cited by 17
Current and Emerging Pharmacotherapeutic Options for Smoking Cessation
Carson‐Chahhoud, K., Brinn, M. P., Robertson, T. A., To-A-Nan, R., Esterman, A., Peters, M. J., & Smith, B. J. (2013) · Substance Abuse Research and Treatment · doi:10.4137/sart.s8108 · Cited by 20
Ussing, C. A., Hansen, C. P., Petersen, J. G., Jensen, A. A., Rohde, L. A. H., Ahring, P. K., Nielsen, E. Ø., Kastrup, J. S., Gajhede, M., Frølund, B., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301409f · Cited by 15
Spruell, T., Colavita, G., Donegan, T., Egawhary, M., Hurley, M., Aveyard, P. N., Johnstone, E. C., Murphy, M. F. G., & Munafo, M. R. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr246 · Cited by 16
Self-citationPhusahat, P., Dilokthornsakul, P., Boonsawat, W., Zaeoue, U., Hansuri, N., Tawinkan, N., Theeranut, A., & Lertsinudom, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013358 · Cited by 18
Ascending single dose pharmacokinetics of cytisine in healthy adult smokers
Jeong, S. H., Sheridan, J. L., Bullen, C., Newcombe, D. A. L., Walker, N. K., & Tingle, M. D. (2018) · Xenobiotica · doi:10.1080/00498254.2018.1557760 · Cited by 15
Wróblewski, K., Petruczynik, A., Tuzimski, T., Przygodzka, D., Buszewicz, G., Kołodziejczyk, P., & Tutka, P. (2019) · Molecules · doi:10.3390/molecules24142580 · Cited by 15
Cytisine versus Nicotine for Smoking Cessation
Zatoński, W. A., & Zatonski, M. Z. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1500342 · Cited by 15
Ross, C. L., & Hansel, T. T. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.003 · Cited by 14
Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial
Rosón, N. F., Rubio, T. M., Pacheco, V. A., García, S. M., Gómez-Bastero, A., Muñoz, C. R., & Polo-Padillo, J. (2017) · Addiction · doi:10.1111/add.13855 · Cited by 15
Castaldelli-Maia, J. M., Martins, S. S., & Walker, N. K. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.05.012 · Cited by 15
George, T. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00031-2 · Cited by 15
Baptisia Poisoning: A New and Toxic Look-alike in the Neighborhood
Anderson, M., Kurtycz, D. F. I., & Cline, J. R. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.09.037 · Cited by 13
Polish Forum for Prevention Guidelines on Smoking: update 2017
Jankowski, P., Kawecka−Jaszcz, K., Kopeć, G., Podolec, J., Pająk, A., Sarnecka, A. K., Zdrojewski, T. R., Czarnecka, D., Malecki, M. T., Nowicka, G., et al. (2017) · Kardiologia Polska · doi:10.5603/kp.2017.0066 · Cited by 12
Tobacco carcinogens and the methionine metabolism in human bladder cancer
Wojtczyk-Miaskowska, A., & Schlichtholz, B. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.06.001 · Cited by 15
Meng, Y., Xiang, S., Qu, L., & Li, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1361186 · Cited by 18
Cytisine for smoking cessation: A 40-day treatment with an induction period
Tinghino, B., Cardellicchio, S., Corso, F., Cresci, C., Pittelli, V., Principe, R., Siracusano, L., Zelano, G., Zagà, V., & Cattaruzza, M. S. (2024) · Tobacco Prevention & Cessation · doi:10.18332/tpc/187556 · Cited by 16
Jeong, S. H., Sheridan, J. L., Newcombe, D. A. L., & Tingle, M. D. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1409916 · Cited by 11
Tindle, H. A., Freiberg, M. S., Gnatienko, N., Blokhina, E. A., Cheng, D. M., Yaroslavtseva, T. V., Bendiks, S., Winter, M. R., Krupitsky, E. M., & Samet, J. H. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100625 · Cited by 13
Smoking Cessation Interventions for Lung Cancer Patients
Carson‐Chahhoud, K., Usmani, Z. A., Robertson, T. A., Mysore, S., & Brinn, M. P. (2013) · Lung Cancer Management · doi:10.2217/lmt.12.55 · Cited by 13
Lung cancer mortality decline among middle-aged men and women in Poland and the UK
Zatoński, W. A., Tukiendorf, A., Zatonski, M. Z., Janik‐Koncewicz, K., Marciniak, A., & Wijatkowska, K. (2017) · Journal of Health Inequalities · doi:10.5114/jhi.2017.74201 · Cited by 10
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Updates in the management of stable chronic obstructive pulmonary disease
Narsingam, S., Bozarth, A. L., & Abdeljalil, A. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1084212 · Cited by 9
Grebenstein, P. E., Harp, J. L., & Rowland, N. (2013) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.012 · Cited by 9
Gendy, M. N. S., Ibrahim, C., Sloan, M. E., & Foll, B. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_253 · Cited by 10
Jacobs, C. A., Fonseca, M., Rigotti, N. A., Benowitz, N. L., Clarke, A., & Cain, D. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac233 · Cited by 10
An Update About Tobacco and Cancer: What Clinicians Should Know
Schroeder, S. A. (2012) · Journal of Cancer Education · doi:10.1007/s13187-012-0327-2 · Cited by 8
(−)-Cytisine: Access to a stereochemically defined and functionally flexible piperidine scaffold
Niwetmarin, W., Campello, H. R., Sparkes, H. A., Aggarwal, V. K., & Gallagher, T. C. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob01456f · Cited by 8
Gültzow, T., Smit, E. S., Crutzen, R., Jolani, S., Hoving, C., & Dirksen, C. D. (2022) · Journal of Medical Internet Research · doi:10.2196/34246 · Cited by 8
Role of nicotine receptor partial agonists in tobacco cessation
Murthy, P., Maity, N., & Chand, P. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124709 · Cited by 8
A Review of the Organic Synthesis and Medicinal Applications of the Natural Product Cytisine
Bartusik‐Aebisher, D., Aebisher, D., & Tutka, P. (2016) · Modern Organic Chemistry Research · doi:10.22606/mocr.2016.11002 · Cited by 7
Pataka, A., Kotoulas, S., Karkala, A., Tzinas, A., Kalamaras, G., Kasnaki, N., Sourla, E., & Stefanidou, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247570 · Cited by 7
Rungruanghiranya, S., Tulatamakit, S., Chittawatanarat, K., Preedapornpakorn, K., Wongphan, T., Sutanthavibul, N., Preechawong, S., & Petborom, P. (2024) · Respirology · doi:10.1111/resp.14787 · Cited by 7
Ramotowski, B., & Budaj, A. (2021) · Kardiologia Polska · doi:10.33963/kp.a2021.0025 · Cited by 7
From the IASLC Tobacco Control Committee
(2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.05.002 · Cited by 6
Cytisine is effective for smoking cessation: should clinicians use it?
Samet, J. M. (2014) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2013-101696 · Cited by 6
An evidence-based guide to smoking cessation therapies
Marshall, A., Siddiqui, F., & Dogar, O. F. (2023) · Journal of Prescribing Practice · doi:10.12968/jprp.2023.5.8.324 · Cited by 7
Jimenez-Ruiz, C. A., Miranda, J. A. R., Picó, A. M., Gutiérrez, R. D. S., Miñana, J. S.-C., Muñoz, J. L., & Sellarés, J. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.11.015 · Cited by 5
Medical management of inpatients with tobacco dependency
Agrawal, S., Evison, M., Ananth, S., Fullerton, D., McDill, H., Perry, M., Pollington, J., Restrick, L., Spencer, E., & Vaghela, A. (2024) · Thorax · doi:10.1136/thorax-2023-220607 · Cited by 6
Torazzi, A., Tedesco, E., Ceccato, S., Santin, L., Campagnari, S., Losso, L., Toldo, S., Casari, R., Arzenton, E., Marini, P., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1350176 · Cited by 5
Huang, E. W.-C., Marks, G. B., Pham, N. Y., Nguyen, T. A., Nguyễn, T. A., Vu, G. V., Nguyen, V. N., Jan, S., Negin, J., Ngo, Q. C., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13203-y · Cited by 5
Wróblewski, K., Szultka‐Młyńska, M., Courtney, R. J., Buszewski, B., & Tutka, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015364 · Cited by 5
Heat capacity of cytisine – the drug for smoking cessation
Czerniecka‐Kubicka, A., Tutka, P., Zarzyka, I., Neilsen, G., Woodfield, B. F., Skotnicki, M., & Pyda, M. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106397 · Cited by 4
Peiffer, G., Underner, M., Perriot, J., Paillot, N., & Renolleau, F. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70495-6 · Cited by 8
Zamboni, L., Campagnari, S., Giordano, R., Fusina, F., Carli, S., Congiu, A., Barbon, I., Melchiori, S., Casari, R., Tedeschi, E., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.940100 · Cited by 5
Zatoński, W. A., Janik‐Koncewicz, K., Stępnicka, Z., Zatońska, K., Połtyn–Zaradna, K., & Herbeć, A. (2020) · Journal of Health Inequalities · doi:10.5114/jhi.2020.102969 · Cited by 4
Update on tobaccoism, approach from the community pharmacy and pharmacological treatments of choice
Juanola, M. C. A. (2022) · Anales de la Real Academia Nacional de Farmacia · doi:10.53519/analesranf.2022.88.03.05 · Cited by 2
Tobacco control collapse in Poland after 2015. Alarming increase in cigarette consumption
Zatoński, W. A., Janik‐Koncewicz, K., Neneman, J., & Gruszczynski, L. A. (2023) · Journal of Health Inequalities · doi:10.5114/jhi.2023.133896 · Cited by 3
Tedesco, E., Ceccato, S., Torazzi, A., Santin, L., Losso, L., Bottardi, A., Casari, R., Melchiori, S., Secchettin, E., Ferrero, V., et al. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03888-5 · Cited by 4
Mucocutaneous complications of smoking cessation therapies
Ladizinski, B., & Lee, K. C. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.05.007 · Cited by 3
Updated evidence-based guide to smoking cessation therapies
Siddiqui, F., Huque, R., & Dogar, O. F. (2016) · British Journal of Community Nursing · doi:10.12968/bjcn.2016.21.12.607 · Cited by 4
Janik‐Koncewicz, K., Zatonski, M. Z., Herbeć, A., & Zatoński, W. A. (2017) · Journal of Health Inequalities · doi:10.5114/jhi.2017.74202 · Cited by 3
Trigo, J. M., & Foll, B. L. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_11 · Cited by 3
Górecka, D., Jassem, E., Pierzchała, W., & Śliwiński, P. (2012) · Advances in respiratory medicine · doi:10.5603/arm.27591 · Cited by 22
Chiu, N., & Chang, C.-J. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_26_19 · Cited by 3
Supporting economically disadvantaged tobacco users to help them stop: time to review priorities?
Siddiqi, K. (2014) · Addiction · doi:10.1111/add.12575 · Cited by 3
Mir, H. R., Heshmati, J., Mullen, K., Baldwin, A., Quirouette, E., Pipe, A., & Reid, R. D. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01591-4 · Cited by 2
Davis, S., Campello, H. R., Gallagher, T. C., & Hunter, W. N. (2020) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x20001168 · Cited by 2
Simple Synthesis of Complex Amines from the Diels–Alder Adducts of (–)-Cytisine
Shivanyuk, A. N., Chuyko, A., Dolgonos, G., FETYUKHIN, V. N., & Lukin, O. V. (2021) · Synthesis · doi:10.1055/s-0040-1706282 · Cited by 2
Batra, A., Düerkop, M., Gertzen, M., Jähne, A., Mühlig, S., & Rüther, T. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00013-8 · Cited by 2
Lando, H. A. (2013) · Addiction · doi:10.1111/add.12007 · Cited by 2
“Health outcomes in COPD smokers using heated tobacco products: a 3‑year follow‑up: comment”
Szymański, F. M., Semczuk-Kaczmarek, K., & Kuna, P. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02753-5 · Cited by 2
Raucherentwöhnung mit Fokus auf onkologische Patienten
Bauer-Kemény, C., & Kreuter, M. (2021) · CME · doi:10.1007/s11298-021-2125-9 · Cited by 1
Türkiye’de Sigara Bırakmada Yeni Medikal Tedavi: Sitizin
Kızıltaş, Ö. (2025) · Bağımlılık Dergisi · doi:10.51982/bagimli.1603413 · Cited by 1
Glenn, D. L., Choi, S. H., & Zimmerman, R. S. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251353251 · Cited by 1
Gökseven, Y., Güllü, E. K., & Öztürk, G. Z. (2025) · Turkish Journal of Family Practice · doi:10.54308/turkjfampract.2025.877 · Cited by 2
Polish consensus on smoking cessation intervention within lung cancer screening
Balwicki, Ł., Klimiuk, K. B., Miller, M., Szurowska, E., Kasza, N., Bidzińska, J., Didkowska, J. A., Cedzyńska, M., Czajkowska‐Malinowska, M., Zdrojewski, T. R., et al. (2025) · Archives of Medical Science · doi:10.5114/aoms/214091 · Cited by 1
Rediscovering cytisine: Why the WHO’s decision matters for global public health
Polosa, R., & Cohen, G. A. (2026) · iScience · doi:10.1016/j.isci.2026.114874 · Cited by 2
An evaluation of cytisinicline for smoking cessation in adult smokers
Rigotti, N. A., & Benowitz, N. L. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2646283 · Cited by 1
Design Strategy for a Smoking Cessation Trial of Survival
Shuster, J. J. (2013) · Clinical and Translational Science · doi:10.1111/cts.12124 · Cited by 1
Management Options in Chronic Obstructive Pulmonary Disease
Desai, H. D., & Dalal, B. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s6563 · Cited by 1
Efficacy and Safety of Medications Use in Tobacco Dependence
Seesin, T. (2014) · Isan Journal of Pharmaceutical Sciences, IJPS (Isan J Pharm Sci) · doi:10.14456/ijps.2014.20 · Cited by 1
NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES
Gambaryan, M. G. (2013) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2013-9-3-280-286 · Cited by 4
Evaluation of pharmacological and non–pharmacological methods of smoking cessation; A Review
Gautam, N., Shivalingesh, K., Sharma, S., Irshad, R., & Satyaki, V. (2020) · Journal of Addiction Medicine and Therapeutic Science · doi:10.17352/2455-3484.000037 · Cited by 3
Worsening of chorea during smoking cessation therapy with cytisine: A case report
Vecchio, S., Maugeri, S., Orso, L., & Somaini, L. (2021) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2021.100018 · Cited by 1
Kirichenko, N., Akulov, E. N., Triberti, P., & Belokobylskij, S. А. (2021) · ZooKeys · doi:10.3897/zookeys.1061.70929 · Cited by 1
Basu, D., Mitra, S., & Vadivelu, N. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1951-2_9 · Cited by 1
Cytisine for smoking cessation
BMJ Publishing Group Ltd (2024) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2024.000009 · Cited by 1
Nowak, K., Szpot, P., Zawadzki, M., & Chłopaś‐Konowałek, A. (2024) · Forensic Toxicology · doi:10.1007/s11419-024-00710-3 · Cited by 2
Update to evidence-based guide to smoking cessation therapies
Siddiqui, F., Huque, R., & Dogar, O. F. (2017) · Nurse Prescribing · doi:10.12968/npre.2017.15.2.77 · Cited by 1
C(5) Site-Selective Functionalization of (S)-Cotinine
Campello, H. R., & Gallagher, T. C. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02704 · Cited by 1
Luepker, R. V. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_8 · Cited by 1
Use of Electronic Nicotine Delivery Systems (ENDS) in Poland in 2019
Janik‐Koncewicz, K., Zatoński, W. A., & Zatonski, M. Z. (2021) · Journal of Health Inequalities · doi:10.5114/jhi.2021.107953 · Cited by 1
Breathing Life Into Lung Cancer Screening Trials
Dresler, C. M., & Evans, W. K. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.08.012 · Cited by 1
The Four Secrets the Drug Companies Don't Want You to Know
LaMattina, J. L. (2012) · Wiley eBooks · doi:10.1002/9781118511329.ch1
Qué deben saber los cardiólogos del tratamiento farmacológico para dejar de fumar
Zabert, G. E., Ruiz, C. J., & Zabert, I. (2011) · Revista Uruguaya de Cardiología · Cited by 2
Pharmacological therapies in smoking cessation: an evidence-based update
Allam, J. S., & Ochoa, C. (2015) · Current Pulmonology Reports · doi:10.1007/s13665-015-0125-5
Cytisine is more effective than nicotine replacement for smoking cessation
Stapleton, J. (2015) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2015-110188
Self-citationBald eine preiswerte Option zur Tabakentwöhunung?
Batra, A. (2012) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-012-0045-7
Tønnesen, P. (2015) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000369502 · Cited by 2
Klein, F. (2014) · Pneumo News · doi:10.1007/s15033-014-0034-2
A New Drug Option for Smoking Cessation
Brett, A. S. (2011) · Journal watch · doi:10.1056/jw201110130000010
Herbeć, A., Janik‐Koncewicz, K., McEwen, A., West, R., & Zatoński, W. A. (2017) · Journal of Health Inequalities · doi:10.5114/jhi.2017.74203 · Cited by 3
Self-citationVaccination against nicotine to facilitate smoking cessation
Raupach, T. (2013) · doi:10.2217/ebo.12.204
Innovative pharmakologische Ansätze zur Behandlung von Suchterkrankungen
Majić, T., Gutwinski, S., Müller, C. A., Schoofs, N., & Heinz, A. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00006-0
Metadata
- Authors
- West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., & Stapleton, J.
- Affiliations
- Cancer Research UK (GB)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- University of Birmingham (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-09-29
- Volume
- 365
- Issue
- 13
- Pages
- 1193-1200
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2023431702
- Cited by
- 234
- References
- 25
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 13 · 2023: 11 · 2022: 21 · 2021: 13 · 2020: 9 · 2019: 10 · 2018: 16 · 2017: 10 · 2016: 11 · 2015: 14 · 2014: 16 · 2013: 28 · 2012: 28
- FWCI
- 17.19
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Portal (King's College London) (publishedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Cancer Research UK
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cytisine, smoking cessation, nicotine dependence, nicotinic acetylcholine receptors, smoking abstinence, pharmacotherapy, gastrointestinal adverse effects, low-cost treatment
- MeSH terms
- Adult, Cystine, Double-Blind Method, Female, Gastrointestinal Diseases, Humans, Male, Middle Aged, Placebos, Smoking Cessation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.